Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
09/2014
09/18/2014WO2014144772A1 Methods of promoting wound healing using crm1 inhibitors
09/18/2014WO2014144169A1 Carm1 inhibitors and uses thereof
09/18/2014WO2014143915A1 Novel crystalline forms
09/18/2014WO2014143608A1 Phthalazines as potassium ion channel inhibitors
09/18/2014WO2014143601A1 CDC7 Inhibitors
09/18/2014WO2014142273A1 Dihydropyridazine-3,5-dione derivative
09/18/2014WO2014142255A1 Heterocyclic compound
09/18/2014WO2014142092A1 Novel pi polyamide
09/18/2014WO2014141181A1 Process for preparing peptide deformylase inhibitors
09/18/2014WO2014141175A1 Novel acrylamide derivatives as antimalarial agents
09/18/2014WO2014141091A1 Pyrrole derivatives as alpha 7 nachr modulators
09/18/2014WO2014141015A1 Pyrazolylbenzo[d]imidazole derivatives
09/18/2014WO2014140582A1 Kinase inhibitors
09/18/2014WO2014140310A1 Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
09/18/2014WO2014140034A1 Improved process for the manufacture of moxonidine
09/18/2014WO2014139388A1 Novel indole derivatives useful as anti-diabetic agents
09/18/2014WO2014139150A1 Substituted pyridizinone derivatives as pde10 inhibitors
09/18/2014WO2014139145A1 Novel pyrimidine and pyridine compounds and usage thereof
09/18/2014WO2013164337A9 Pyrimidine derivatives for the treatment of bacterial diseases
09/18/2014US20140275711 1-(Arylmethyl)-5,6,7,8-tetrahydroquinazolline-2,4-diones and Analogs and the Use Thereof
09/18/2014US20140275555 Articles and methods comprising persistent carbenes and related compositions
09/18/2014US20140275541 Total synthesis of thaxtomin a analogues and their intermediates
09/18/2014US20140275527 Azetidines as MEK Inhibitors for the Treatment of Proliferative Diseases
09/18/2014US20140275524 Molecules having certain pesticidal utilities, and intermediates, compositions, and processes related thereto
09/18/2014US20140275121 CDC7 Inhibitors
09/18/2014US20140275118 Substituted 2-azabicycles and their use as orexin receptor modulators
09/18/2014US20140275105 Crystal of androgen receptor antagonistic compound
09/18/2014US20140275102 Solid State Forms of 6-[4-[3-((R)-2-Methylpyrrolidine-1-yl)-propoxy]phenyl] 2H-pyridazine-3-one Hydrochloride
09/18/2014US20140275100 Pyridazine derivatives useful in therapy
09/18/2014US20140275087 Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
09/18/2014US20140275086 Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
09/18/2014US20140275079 Pyrrole amide inhibitors
09/18/2014US20140275076 Heterocyclic substituted-3-heteroarylidenyl-2-indolinone derivative
09/18/2014US20140275075 Isatin compounds, compositions and methods for treatment of degenerative diseases and disorders
09/18/2014US20140275074 Heterocyclic derivative having pgd2 receptor antagonist activity
09/18/2014US20140275059 Dna-pk inhibitors
09/18/2014US20140275049 SUBSTITUTED PYRAZOLE ANALOGS As RAR ANTAGONISTS
09/18/2014US20140275033 Inhibitors of kinases and cancer stem cells, and methods of preparation and use thereof
09/18/2014US20140275029 1,2,6-substituted benzimidazoles as flap modulators
09/18/2014US20140275025 Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
09/18/2014US20140275024 Dna-pk inhibitors
09/18/2014US20140275006 Azole derivative
09/18/2014US20140275005 Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof
09/18/2014US20140275003 Biaryl amide compounds as kinase inhibitors
09/18/2014US20140274950 Pyrazole compounds, compositions and methods for treatment of degenerative diseases and disorders
09/18/2014US20140271662 Pyrazole derivatives as protein kinase modulators
09/17/2014EP2778162A1 Fluorescent whitening compositions containing triazine derivatives
09/17/2014EP2778161A1 Two-photon fluorescent probe using naphthalene as matrix and preparation method and use thereof
09/17/2014EP2776444A1 Dihydropteridinones
09/17/2014EP2776437A1 Modulators of opioid receptors and methods of use thereof
09/17/2014EP2776426A1 New cyclohexylamine derivatives having beta 2 adrenergic agonist and m3 muscarinic antagonist activities
09/17/2014EP2776425A1 New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities
09/17/2014EP2776424A1 Substituted pyrazolyl-based carboxamide and urea derivatives bearing a phenyl moiety substituted with an n-cyclic group as vanilloid receptor ligands
09/17/2014EP2776423A1 Phenyl-substituted nicotinic ligands, and methods of use thereof
09/17/2014EP2776422A1 Compounds useful as inhibitors of atr kinase
09/17/2014EP2776421A1 Compounds useful as inhibitors of atr kinase
09/17/2014EP2776416A1 Pharmaceutical compounds
09/17/2014EP2776411A1 Modulators of c3a receptors
09/17/2014EP2776408A1 Anticancer benzopyrazines via the inhibition of fgfr kinases
09/17/2014EP2776405A1 2-thiopyrimidinones
09/17/2014EP2776403A1 2,5-dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (fprl-1) receptor modulators
09/17/2014EP2776387A1 Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction
09/17/2014EP2776023A1 Meglumine salt formulations of 1-(5,6-dichloro-1h-benzo[d]imidazol-2-yl)-1h-pyrazole-4-carboxylic acid
09/16/2014US8835689 Substituted 4-aminocyclohexane derivatives
09/16/2014US8835648 Hedgehog pathway antagonists and therapeutic applications thereof
09/16/2014US8835635 Amorphous form of vilazodone hydrochloride substantially free of crystalline forms
09/16/2014US8835634 Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
09/16/2014US8835633 Process for the preparation of benzoimidazol-2-yl pyrimidine derivatives
09/16/2014US8835632 Methods to increase the photostability of dyes
09/16/2014US8835631 Therapeutic agent for cerebral infarction
09/16/2014US8835629 Anti-cancer agents
09/16/2014US8835482 Substituted indazole and aza-indazole derivatives as gamma secretase modulators
09/16/2014US8835480 Inhibitors for steroid response elements and related methods
09/16/2014US8835476 Synthesis of novel antimicrobials
09/16/2014US8835472 Compounds, pharmaceutical compositions and uses thereof
09/16/2014US8835461 Substituted 3-hydroxy-4-pyridone derivative
09/16/2014US8835458 Quinoline or quinazoline derivatives with apoptosis inducing activity on cells
09/16/2014US8835440 Cyclic pyrimidin-4-carboxamides as CCR2 receptor antagonists for treatment of inflammation, asthma and COPD
09/16/2014US8835436 Arylpiperazine-containing imidazole 4-carboxamide derivatives and pharmaceutical composition comprising same
09/16/2014US8835434 Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
09/16/2014US8835432 Heterocyclic compounds and their uses
09/16/2014US8835430 2,4-pyrimidinediamine compounds and their uses
09/16/2014US8835421 Benzimidazole linked pyrrolo[2,1-c[1,4] benzodiazepine hybrids as potential antitumour agents and process for the preparation thereof
09/16/2014US8835420 Azaindole derivatives
09/16/2014US8835419 Substituted anilines as CCR(4) antagonists
09/16/2014US8835418 Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
09/16/2014US8835393 Inhibitors of IAP
09/16/2014CA2781066C Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use
09/16/2014CA2623202C Hydrazide compound and pesticidal use of the same
09/16/2014CA2604895C (1h-indol-7-yl)-( (pyrimidin-2-ylamino) methanone derivatives and related compounds as igf-r1 inhibitors for the treatment of cancer
09/12/2014WO2014138302A1 Quinazolinone antibiotics
09/12/2014WO2014137104A1 Compound for organic electronic element, organic electronic element comprising compound, and electronic device using organic electronic element
09/12/2014WO2014136860A1 Compound, luminescent material and organic luminescent element
09/12/2014WO2014135955A1 Pyrimidine carboxamides as sodium channel blockers
09/12/2014WO2014135876A1 Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor
09/12/2014WO2014135654A1 Herbicidal compounds
09/12/2014WO2014135495A1 Antiviral compounds
09/12/2014WO2014135483A1 Antiviral compounds
09/12/2014WO2014135478A1 Fungicidal 3-{heterocyclyl[(heterocyclylmethoxy)imino]methyl}-oxadiazolone derivatives
09/12/2014WO2014135471A1 Antiviral compounds
1 ... 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 ... 626